219 related articles for article (PubMed ID: 21188243)
1. Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis.
Ishikawa T; Nakagawa H; Hagiya Y; Nonoguchi N; Miyatake S; Kuroiwa T
Adv Pharmacol Sci; 2010; 2010():587306. PubMed ID: 21188243
[TBL] [Abstract][Full Text] [Related]
2. Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.
Ishikawa T; Kajimoto Y; Sun W; Nakagawa H; Inoue Y; Ikegami Y; Miyatake S; Kuroiwa T
J Pharm Sci; 2013 Sep; 102(9):3058-69. PubMed ID: 23650051
[TBL] [Abstract][Full Text] [Related]
3. Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.
Ishikawa T; Kajimoto Y; Inoue Y; Ikegami Y; Kuroiwa T
Adv Cancer Res; 2015; 125():197-216. PubMed ID: 25640271
[TBL] [Abstract][Full Text] [Related]
4. Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy.
Hagiya Y; Adachi T; Ogura S; An R; Tamura A; Nakagawa H; Okura I; Mochizuki T; Ishikawa T
J Exp Ther Oncol; 2008; 7(2):153-67. PubMed ID: 18771089
[TBL] [Abstract][Full Text] [Related]
5. Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors.
Ishikawa T; Takahashi K; Ikeda N; Kajimoto Y; Hagiya Y; Ogura S; Miyatake S; Kuroiwa T
Pharmaceutics; 2011 Sep; 3(3):615-35. PubMed ID: 24310600
[TBL] [Abstract][Full Text] [Related]
6. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
Liu W; Baer MR; Bowman MJ; Pera P; Zheng X; Morgan J; Pandey RA; Oseroff AR
Clin Cancer Res; 2007 Apr; 13(8):2463-70. PubMed ID: 17438106
[TBL] [Abstract][Full Text] [Related]
7. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
[TBL] [Abstract][Full Text] [Related]
8. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
[TBL] [Abstract][Full Text] [Related]
9. Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics.
Ishikawa T; Nakagawa H
J Exp Ther Oncol; 2009; 8(1):5-24. PubMed ID: 19827267
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs.
Tamura A; Onishi Y; An R; Koshiba S; Wakabayashi K; Hoshijima K; Priebe W; Yoshida T; Kometani S; Matsubara T; Mikuriya K; Ishikawa T
Drug Metab Pharmacokinet; 2007 Dec; 22(6):428-40. PubMed ID: 18159130
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.
Pick A; Wiese M
ChemMedChem; 2012 Apr; 7(4):650-62. PubMed ID: 22354538
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the Effect of Methyl Pyropheophorbide-a-Mediated Photodynamic Therapy was Achieved by Increasing ROS through Inhibition of Nrf2-HO-1 or Nrf2-ABCG2 Signaling.
Tian S; Yong M; Zhu J; Zhang L; Pan L; Chen Q; Li KT; Kong YH; Jiang Y; Yu TH; Yu LH; Bai DQ
Anticancer Agents Med Chem; 2017; 17(13):1824-1836. PubMed ID: 28356018
[TBL] [Abstract][Full Text] [Related]
13. The role of ABCG2 in modulating responses to anti-cancer photodynamic therapy.
Khot MI; Downey CL; Armstrong G; Svavarsdottir HS; Jarral F; Andrew H; Jayne DG
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101579. PubMed ID: 31639455
[TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro.
Houghton PJ; Germain GS; Harwood FC; Schuetz JD; Stewart CF; Buchdunger E; Traxler P
Cancer Res; 2004 Apr; 64(7):2333-7. PubMed ID: 15059881
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy.
Bebes A; Nagy T; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M
J Photochem Photobiol B; 2011 Nov; 105(2):162-6. PubMed ID: 21911299
[TBL] [Abstract][Full Text] [Related]
16. Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.
Morgan J; Jackson JD; Zheng X; Pandey SK; Pandey RK
Mol Pharm; 2010 Oct; 7(5):1789-804. PubMed ID: 20684544
[TBL] [Abstract][Full Text] [Related]
17. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
18. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced phototoxicity evoked by inhibition of human ABC transporter ABCG2: development of in vitro high-speed screening systems.
Tamura A; An R; Hagiya Y; Hoshijima K; Yoshida T; Mikuriya K; Ishikawa T
Expert Opin Drug Metab Toxicol; 2008 Mar; 4(3):255-72. PubMed ID: 18363541
[TBL] [Abstract][Full Text] [Related]
20. Natural Compounds Modulate Drug Transporter Mediated Oral Cancer Treatment.
Yang H; Wei YC; Li WC; Chen HY; Lin HY; Chiang CP; Chen HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32957726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]